Aflatoxin exposure and primary liver cancer in Ghana
(2025)
Journal Article
Nartey, Y., Kwame Akyea, R., Cox, B., & Vanderpuye, V. (2025). Aflatoxin exposure and primary liver cancer in Ghana. BMJ Global Health, 10(6), Article e017626. https://doi.org/10.1136/bmjgh-2024-017626
All Outputs (3)
Qualitative study exploring knowledge and attitudes towards dementia risk prediction, barriers to dementia services and service improvement recommendations with diverse populations in England (2025)
Journal Article
Bajwa, R., Hanjari, M., Al-Oraibi, A., Akyea, R., Brar, M., Robinson, L., Stephan, B. C., Qureshi, N., & Bains, M. (2025). Qualitative study exploring knowledge and attitudes towards dementia risk prediction, barriers to dementia services and service improvement recommendations with diverse populations in England. BMJ Open, 15(5), Article e092370. https://doi.org/10.1136/bmjopen-2024-092370Objectives: This study explored knowledge of dementia, attitudes towards dementia risk prediction and barriers and facilitators to accessing dementia services for diverse populations in England.
Design: Qualitative study using task group methodology... Read More about Qualitative study exploring knowledge and attitudes towards dementia risk prediction, barriers to dementia services and service improvement recommendations with diverse populations in England.
Non-inferiority trials in stroke research: what are they, and how should we interpret them? (2025)
Journal Article
Li, L., Lioutas, V.-A., Akyea, R. K., Gerner, S., Lau, K. K., Ramage, E., Katsanos, A. H., Howard, G., & Bath, P. M. (2025). Non-inferiority trials in stroke research: what are they, and how should we interpret them?. Journal of Stroke, 27(1), 41-51. https://doi.org/10.5853/jos.2024.03923Randomized clinical trials are important in both clinical and academic stroke communities with increasing numbers of new design concepts emerging. One of the “less traditional” designs that have gained increasing interest in the last decade is non-in... Read More about Non-inferiority trials in stroke research: what are they, and how should we interpret them?.